Your browser doesn't support javascript.
loading
MiR-548c-3p inhibits the proliferation, migration and invasion of human breast cancer cell by targeting E2F3.
Tan, Pei-Yi; Wen, Liu-Jing; Li, Hua-Nan; Chai, Shi-Wei.
Afiliação
  • Tan PY; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China.
  • Wen LJ; National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China.
  • Li HN; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China.
  • Chai SW; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China. chaishiwei791109@sina.com.
Cytotechnology ; 72(5): 751-761, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32902720
ABSTRACT
MiR-548 has been reported to be involved in a variety of tumor processes, but its function in breast cancer remains unclear. In this study, we found that miR-548 was low expressed in breast cancer tissues and cells compared with normal control. We then examined whether up-regulation of miR-548 could improve the progression of breast cancer. Our results indicate that up-regulation of miR-548 significantly inhibits cell proliferation, migration andinvasion, and induces apoptosis in breast cancer cells. Further studies showed that miR-548 could specifically inhibit E2F3 expression. Moreover, rescue test showed that up-regulation of E2F2 could reverse the effect of miR-548 on proliferation, migration, invasion and apoptosis of breast cancer cells. In general, miR-548 could improve the progression of breast cancer. By targeting E2F2, which may make a potential target for the treatment of breast cancer.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article